POWEL H BROWN to Clinical Trials as Topic
This is a "connection" page, showing publications POWEL H BROWN has written about Clinical Trials as Topic.
Connection Strength
0.365
-
Chemoprevention clinical trials: it is time to turn success into progress. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1531-2.
Score: 0.141
-
Targeting the HER/EGFR/ErbB family to prevent breast cancer. Cancer Prev Res (Phila). 2011 Aug; 4(8):1149-57.
Score: 0.046
-
Drug development for cancer chemoprevention: focus on molecular targets. Semin Oncol. 2010 Aug; 37(4):345-58.
Score: 0.043
-
Translational approaches for the prevention of estrogen receptor-negative breast cancer. Eur J Cancer Prev. 2007 Jun; 16(3):203-15.
Score: 0.035
-
Prevention of breast cancer: current state of the science and future opportunities. Expert Opin Investig Drugs. 2006 Dec; 15(12):1583-600.
Score: 0.034
-
Defining the role of raloxifene for the prevention of breast cancer. J Natl Cancer Inst. 2004 Dec 01; 96(23):1731-3.
Score: 0.029
-
Chemoprevention of breast cancer. Breast Cancer Res Treat. 2000 Jul; 62(1):1-17.
Score: 0.022
-
A SNP in steroid receptor coactivator-1 disrupts a GSK3? phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol. 2012 Feb; 26(2):220-7.
Score: 0.012
-
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop. Lung Cancer. 1995 Mar; 12(1-2):91-103.
Score: 0.004